hz 515H7Alternative Names: F-50067; hz-515H7; mAb hz515H7; Project F50067
Latest Information Update: 05 May 2016
At a glance
- Originator Pierre Fabre
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action CCR4 receptor antagonists; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Cancer